jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

April. 16, 2019

July. 11, 2025

jRCTs051190006

Prospective Evaluation of the Molecular Effects of Itraconazole as an anti-cancer agent: A Window of Opportunity Study (Window trial)

Window trial (Window trial)

Tsubamoto Hiroshi

Hyogo Medical University Hospital

Mukogawa 1-1, Nishinomiya, Hyogo

+81-798-45-6481

tsuba@hyo-med.ac.jp

Tsubamoto Hiroshi

Hyogo Medical University Hospital

Mukogawa 1-1, Nishinomiya, Hyogo

+81-798-45-6481

tsuba@hyo-med.ac.jp

Suspended

Aug. 10, 2015

Sept. 24, 2015
200

Interventional

single arm study

double blind

no treatment control/standard of care control

single assignment

treatment purpose

Patients who have window period before standard treatment
And who have no standard treatment

Patients who have drugs which interferes CYP3A

20age old over
No limit

Both

Solid tumor

Administration of itraconazole for 2~4 weeks

Repurposing, window trial

drug repositioning

D009369

D058492

Ki-67 index, serological and/or radiological response

Symptom control ratio, Response rate
Adverse events
Biomarker using tissue and blood
Identification of new target

Kobe city hospital organization certified review board
2-1-1, Minatojima-minamimachi Chuo-ku, Kobe-city, Hyogo

+81-78-302-5176

c_crb@kcho.jp
Approval

Mar. 15, 2019

UMIN000018388
University Hospital Medical Information Network

none

History of Changes

No Publication date
8 July. 11, 2025 (this page) Changes
7 April. 26, 2024 Detail Changes
6 Nov. 10, 2023 Detail Changes
5 July. 06, 2023 Detail Changes
4 Oct. 24, 2022 Detail Changes
3 Mar. 31, 2021 Detail Changes
2 Mar. 11, 2020 Detail Changes
1 April. 16, 2019 Detail